INTRODUCTION: Vasopressin is a novel vasopressor agent used for intractable hypotension. There is little published data available on its use in the poisoned patient. We performed a randomized, controlled, blinded trial in a porcine model to study the effects of vasopressin infusion on mean arterial pressure after verapamil poisoning. METHODS: Eighteen anesthetized monitored swine received a verapamil infusion of 1 mg/kg/hr until the mean arterial pressure (MAP) had decreased to 70% of baseline. At this time, a continuous infusion of either vasopressin (0.01 U/kg/min) or an equal volume of normal saline was initiated. The swine were monitored for 60 minutes after initiation of the study infusion. The primary outcome was MAP. RESULTS: There was no statistically significant difference between the two groups in MAP, cardiac output or systemic vascular resistance. One half (four of eight) of the animals in the vasopressin group died, compared with 20% (two of ten) of those in the saline group. CONCLUSIONS: Vasopressin infusion decreased the survival of verapamil-poisoned swine when compared to those treated with saline alone in this experimental model.
INTRODUCTION:Vasopressin is a novel vasopressor agent used for intractable hypotension. There is little published data available on its use in the poisoned patient. We performed a randomized, controlled, blinded trial in a porcine model to study the effects of vasopressin infusion on mean arterial pressure after verapamilpoisoning. METHODS: Eighteen anesthetized monitored swine received a verapamil infusion of 1 mg/kg/hr until the mean arterial pressure (MAP) had decreased to 70% of baseline. At this time, a continuous infusion of either vasopressin (0.01 U/kg/min) or an equal volume of normal saline was initiated. The swine were monitored for 60 minutes after initiation of the study infusion. The primary outcome was MAP. RESULTS: There was no statistically significant difference between the two groups in MAP, cardiac output or systemic vascular resistance. One half (four of eight) of the animals in the vasopressin group died, compared with 20% (two of ten) of those in the saline group. CONCLUSIONS:Vasopressin infusion decreased the survival of verapamil-poisoned swine when compared to those treated with saline alone in this experimental model.
Authors: Karl H Stadlbauer; Horst G Wagner-Berger; Volker Wenzel; Wolfgang G Voelckel; Anette C Krismer; Günter Klima; Klaus Rheinberger; Sebastian Pechlaner; Viktoria D Mayr; Karl H Lindner Journal: Anesth Analg Date: 2003-06 Impact factor: 5.108
Authors: William A Watson; Toby L Litovitz; Wendy Klein-Schwartz; George C Rodgers; Jessica Youniss; Nicole Reid; Wayne G Rouse; Rebecca S Rembert; Douglas Borys Journal: Am J Emerg Med Date: 2004-09 Impact factor: 2.469
Authors: Karl B Kern; Joseph H Heidenreich; Travis A Higdon; Robert A Berg; Ronald W Hilwig; Arthur B Sanders; Nathan Anavy; Gordon A Ewy Journal: Crit Care Med Date: 2004-09 Impact factor: 7.598
Authors: Karl H Stadlbauer; Horst G Wagner-Berger; Claus Raedler; Wolfgang G Voelckel; Volker Wenzel; Anette C Krismer; Guenter Klima; Klaus Rheinberger; Walter Nussbaumer; Daniel Pressmar; Karl H Lindner; Alfred Königsrainer Journal: Anesthesiology Date: 2003-03 Impact factor: 7.892
Authors: Birgit Schwarz; Peter Mair; Claus Raedler; Diana Deckert; Volker Wenzel; Karl H Lindner Journal: Crit Care Med Date: 2002-06 Impact factor: 7.598
Authors: Mary-Beth Malay; Jennifer L Ashton; Katherine Dahl; Edward B Savage; Sherryl A Burchell; Robert C Ashton; Robert R Sciacca; Juan A Oliver; Donald W Landry Journal: Crit Care Med Date: 2004-06 Impact factor: 7.598
Authors: Maude St-Onge; Kurt Anseeuw; Frank Lee Cantrell; Ian C Gilchrist; Philippe Hantson; Benoit Bailey; Valéry Lavergne; Sophie Gosselin; William Kerns; Martin Laliberté; Eric J Lavonas; David N Juurlink; John Muscedere; Chen-Chang Yang; Tasnim Sinuff; Michael Rieder; Bruno Mégarbane Journal: Crit Care Med Date: 2017-03 Impact factor: 7.598
Authors: M St-Onge; P-A Dubé; S Gosselin; C Guimont; J Godwin; P M Archambault; J-M Chauny; A J Frenette; M Darveau; N Le Sage; J Poitras; J Provencher; D N Juurlink; R Blais Journal: Clin Toxicol (Phila) Date: 2014-10-06 Impact factor: 4.467